Paul McDonagh
Chief Scientific Officer and Founder @ Archetype Therapeutics, Inc. | AI-native drug discovery
- Role
- Chief Scientific Officer and Founder at Archetype Therapeutics, Inc
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Paul McDonagh
With over two decades of experience in bioinformatics, computational biology, and molecular biology, I am currently the Chief Scientific Officer at Archetype Therapeutics. My mission is to bridge the translational gap in drug discovery by leveraging AI, chemoinformatics, and real-world evidence to revolutionize therapeutic development. Passionate about utilizing clinicogenomic data to connect disease biology with clinical outcomes, I bring diverse perspectives and innovative strategies to our team. At Archetype Therapeutics, I lead efforts to develop an AI-native drug discovery platform that simulates therapeutic molecule testing end-to-end, accelerating breakthroughs in patient care. By integrating cutting-edge technologies with deep scientific expertise, our team is advancing treatments tailored to specific disease cohorts. My work is grounded in collaboration and a commitment to transforming patients\' lives.
Experience
Chief Scientific Officer and Founder
Jan 2023 — Present · Boston, MA, US
AI-native drug discovery and development. See: co-founders have spent over two decades working with world-class teams in pharmaceutical companies and analytics startups with a focus on utilizing patient clinicogenomic data to characterize disease and to link disease-specific biology with clinical outcomes. What has been missing is the ability to test existing and novel therapeutic molecules in silico end-to-end from a proposed molecule to a clinical readout in a patient cohort of interest. Finally, leveraging advances in AI, chemoinformatic tools, and real-world evidence (RWE) patient data, we have in Archetype built a platform to bridge the translational gap between drug discovery and patient disease outcomes. We have leveraged this platform to discover and repurpose small molecule therapeutics in lung cancer, prostate cancer, melanoma, and IPF. i•••@archetypetx.com
Education
University of Leicester
Ph.D, Biochemistry and Protein structure
University of Leicester
B.Sc, Biological Science
1989 — 1993
The Wharton School
Certificate, Entrepreneurship/Entrepreneurial Studies
2019
University of Washington
Cert, C Programming
University of Washington
Cert, C++ programming
Skills
- Objective-C
- Biomarkers
- R
- Capacity Planning
- Biomarker Discovery
- Java
- Databases
- Biostatistics
- Bayesian Statistics
- Bayesian Networks
- Cross-Functional Team Leadership
- C/C++ Stl
- Hadoop
- Microarray Analysis
- Amazon Web Services (Aws)
- High Performance Computing
- Biotechnology
- Project Management
- Systems Biology
- Artificial Intelligence
- Genetics
- Bioinformatics
- Mapreduce
- Functional Genomics
- Science
- Life Sciences
- Bayesi
- Software Development
- Machine Learning
- Dna Sequencing
- Personalized Medicine
- Computational Biology
- Ios Development
- Molecular Biology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.